UBS/CALL/SONOVA HLDG N/300.005/0.02/20.09.24 Stock UBS/CALL/SONOVA HLDG N/300.005/0.02/20.09.24
Add to a list
To use this feature you must be a member
Log inSign up

UBS/CALL/SONOVA HLDG N/300.005/0.02/20.09.24 Share Price

Warrant

PSOOQU

CH1246587260

Real-time Bid/Ask 02:15:25 01/07/2024 pm IST
0.09 CHF / 0.1 CHF +18.75% Intraday chart for UBS/CALL/SONOVA HLDG N/300.005/0.02/20.09.24
Current month-57.89%
1 month-70.37%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart SONOVA HOLDING AG
Chart UBS/CALL/SONOVA HLDG N/300.005/0.02/20.09.24

Latest news about SONOVA HOLDING AG

AlphaValue/Baader Europe Lowers Price Target on Sonova, Maintains Add Recommendation MT
Ex-dividend day for final dividend FA
Annual General Shareholders’ Meeting 2024: Sonova shareholders approve all motions of the Board of Directors EQ
SONOVA HOLDING : Beneficiary of innovation quotient via planned product launches Alphavalue
More news

Quotes 5-day view

Date Price Change
25/24/25 0.08 -11.11%

Delayed Quote Swiss Exchange

Last update June 25, 2024 at 08:50 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying SONOVA HOLDING AG
Issuer UBS
PSOOQU
ISINCH1246587260
Date issued 20/03/2023
Strike 300 CHF
Maturity 20/09/2024 (82 Days)
Parity 50 : 1
Emission price 0.32 CHF
Emission volume N/A
Settlement physique
Currency CHF

Technical Indicators

Highest since issue 0.69 CHF
Lowest since issue 0.05 CHF
Delta0.29x
Omega 15.76
Premium8.71x
Gearing53.49x
Moneyness 0.9360
Difference Strike 21.11 CHF
Difference Strike %+7.03%
Spread 0.01 CHF
Spread %9.09%
Theoretical value 0.1000
Implied Volatility 22.35 %
Total Loss Probability 74.84 %
Intrinsic value 0.000000
Present value 0.1000
Break even 305.01 CHF
Theta-0.01x
Vega0.01x
Rho0x

Company Profile

Sonova Holding AG is the world's leading provider of innovative hearing solutions. Its broad product portfolio includes traditional hearing aids, cochlear implants and wireless communication systems. Net sales break down by family of products as follows: - hearing aids (92.3%); - cochlear implants (7.7%). The geographical breakdown of sales is as follows: Switzerland (1.2%%), Europe/Middle East/Africa (48.8%), the United States (30.8%), the Americas (7.3%) and Asia/Pacific (11.9%).
Sector
-
More about the company

Ratings for Sonova Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Sonova Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
277.6 CHF
Average target price
284.8 CHF
Spread / Average Target
+2.60%
Consensus
  1. Stock Market
  2. Warrants
  3. PSOOQU Warrant